Global markets
Sun Pharma Acquires Organon for $11.75 Billion
On April 26, Sun Pharma of India agreed to acquire U.S. pharmaceutical firm Organon for $11.75 billion, a landmark cross-border healthcare M&A that bolstered late-April market momentum.
Primary sources · 1